SFA Therapeutics

Emerging

Company Overview

SFA Therapeutics is a Philadelphia-based clinical-stage biopharmaceutical company developing oral small-molecule Treg modulators that restore immune homeostasis for treating autoimmune diseases and cancer without broad immune suppression. The company has raised $9.13M from investors including Savantus Ventures and Ben Franklin Technology Partners, announced positive Phase 1b safety data for SFA-002 in psoriasis (March 2025), and was nominated for the 2025 Prix Galien USA Best Startup award.

Revenue
$9.13M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

SFA Therapeutics is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How SFA Therapeutics performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for SFA Therapeutics

See exactly how SFA Therapeutics ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how SFA Therapeutics stacks up against competitors with our detailed comparison tool.

Start Comparison